Importantly, these medications significantly slow gastric emptyingthe rate at which food moves from the stomach into the small intestinethough this effect may attenuate somewhat with continued use
Novo has since launched a broad late-stage program for CagriSema, including the Phase III trials REDEFINE 1, which is assessing its efficacy as a weight loss therapy, and REDEFINE 2, designed to include type 2 diabetes patients with excess body weight
A number of MASH patients with type 2 diabetes had low blood sugar levels with use of the therapy
In absolute terms, breast cancer risk in the matched analysis was 1.62% among GLP-1-exposed women and 2.31% among matched women without exposure, corresponding to an absolute risk reduction of 0.69% during the study period
Every IV drip is built on the same sterile fluid base, and what separates 1 formula from another is the specific combination of iv therapy ingredients layered on top